State of the Science Summit - Gastrointestinal Cancers: Chaired by Syma Iqbal, MD, and Anthony El-Khoueiry, MD

Commentary
Article

In Partnership With:

State of the Science Summit - Gastrointestinal Cancers: Chaired by Syma Iqbal, MD, and Anthony El-Khoueiry, MD

State of the Science Summit - Gastrointestinal Cancers: Chaired by Syma Iqbal, MD, and Anthony El-Khoueiry, MD

State of the Science Summit - Gastrointestinal Cancers: Chaired by Syma Iqbal, MD, and Anthony El-Khoueiry, MD

Speakers

  • Syma Iqbal, MD | USC Norris Comprehensive Cancer Center
  • Anthony El-Khoueiry, MD | USC Norris Comprehensive Cancer Center
  • Heinz-Josef Lenz, MD | USC Norris Comprehensive Cancer Center
  • Sandra Danielle Algaze, MD | USC Norris Comprehensive Cancer Center
  • Diana L. Hanna, MD | USC Norris Comprehensive Cancer Center
  • Steven Robert Grossman, MD | USC Norris Comprehensive Cancer Center

Topics

  • Management of HER2+ Metastatic Colorectal Cancers
  • Novel Approaches to the Treatment of Rectal Cancer
  • Expanding Options in the Treatment of Esophagogastric Cancers
  • TKI-Based Therapies in Hepatocellular Carcinoma (HCC)
  • Updates in Metastatic Pancreatic Cancer
  • The Evolving Treatment Landscape of Biliary Tract Cancer
Related Videos
Video 6 - "Patient Case 2: A 62-Year-Old Woman with Metastatic Rectal Cancer"
Video 5 - "Adverse Events Associated With TAS-102 Plus Bevacizumab in CRC"
Michael J. Overman, MD
Ilyas Sahin, assistant professor, Medicine, Department of Medicine, Division of Hematology & Oncology, University of Florida College of Medicine
Michael J. Overman, MD
Manish A. Shah, MD, director, Gastrointestinal Oncology Program, Weill Cornell Medicine; chief, Solid Tumor Service, co-director, Center for Advanced Digestive Disease, NewYork Presbyterian
Katrina S. Pedersen, MD, MS
Efrat Dotan, MD
In this fifth episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss next steps for research, including vaccination strategies, personalized cellular therapies, and more.
In this fourth episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts discuss research efforts being made with organoids to address existing questions with immunotherapy and the exploration of multimodality approaches to improve outcomes.